Trial Profile
Phase III trial of fosbretabulin in combination with chemotherapy and radiotherapy as first-line treatment in patients with advanced non-small cell lung cancer.
Status:
Not stated
Phase of Trial:
Phase III
Latest Information Update: 22 Nov 2011
Price :
$35
*
At a glance
- Drugs Fosbretabulin (Primary) ; Antineoplastics
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 05 Mar 2008 New trial record.